FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138956466> ?p ?o ?g. }

• W2138956466 endingPage "1870" @default.
• W2138956466 startingPage "1870" @default.
• W2138956466 abstract "Clinical whole-exome sequencing is increasingly used for diagnostic evaluation of patients with suspected genetic disorders.To perform clinical whole-exome sequencing and report (1) the rate of molecular diagnosis among phenotypic groups, (2) the spectrum of genetic alterations contributing to disease, and (3) the prevalence of medically actionable incidental findings such as FBN1 mutations causing Marfan syndrome.Observational study of 2000 consecutive patients with clinical whole-exome sequencing analyzed between June 2012 and August 2014. Whole-exome sequencing tests were performed at a clinical genetics laboratory in the United States. Results were reported by clinical molecular geneticists certified by the American Board of Medical Genetics and Genomics. Tests were ordered by the patient's physician. The patients were primarily pediatric (1756 [88%]; mean age, 6 years; 888 females [44%], 1101 males [55%], and 11 fetuses [1% gender unknown]), demonstrating diverse clinical manifestations most often including nervous system dysfunction such as developmental delay.Whole-exome sequencing diagnosis rate overall and by phenotypic category, mode of inheritance, spectrum of genetic events, and reporting of incidental findings.A molecular diagnosis was reported for 504 patients (25.2%) with 58% of the diagnostic mutations not previously reported. Molecular diagnosis rates for each phenotypic category were 143/526 (27.2%; 95% CI, 23.5%-31.2%) for the neurological group, 282/1147 (24.6%; 95% CI, 22.1%-27.2%) for the neurological plus other organ systems group, 30/83 (36.1%; 95% CI, 26.1%-47.5%) for the specific neurological group, and 49/244 (20.1%; 95% CI, 15.6%-25.8%) for the nonneurological group. The Mendelian disease patterns of the 527 molecular diagnoses included 280 (53.1%) autosomal dominant, 181 (34.3%) autosomal recessive (including 5 with uniparental disomy), 65 (12.3%) X-linked, and 1 (0.2%) mitochondrial. Of 504 patients with a molecular diagnosis, 23 (4.6%) had blended phenotypes resulting from 2 single gene defects. About 30% of the positive cases harbored mutations in disease genes reported since 2011. There were 95 medically actionable incidental findings in genes unrelated to the phenotype but with immediate implications for management in 92 patients (4.6%), including 59 patients (3%) with mutations in genes recommended for reporting by the American College of Medical Genetics and Genomics.Whole-exome sequencing provided a potential molecular diagnosis for 25% of a large cohort of patients referred for evaluation of suspected genetic conditions, including detection of rare genetic events and new mutations contributing to disease. The yield of whole-exome sequencing may offer advantages over traditional molecular diagnostic approaches in certain patients." @default.
• W2138956466 created "2016-06-24" @default.
• W2138956466 creator A5000612576 @default.
• W2138956466 creator A5003762954 @default.
• W2138956466 creator A5005303346 @default.
• W2138956466 creator A5006247268 @default.
• W2138956466 creator A5006293085 @default.
• W2138956466 creator A5013612745 @default.
• W2138956466 creator A5015102287 @default.
• W2138956466 creator A5017947172 @default.
• W2138956466 creator A5019877596 @default.
• W2138956466 creator A5022934107 @default.
• W2138956466 creator A5025738262 @default.
• W2138956466 creator A5028202253 @default.
• W2138956466 creator A5028969570 @default.
• W2138956466 creator A5031479743 @default.
• W2138956466 creator A5032114848 @default.
• W2138956466 creator A5032833916 @default.
• W2138956466 creator A5037749785 @default.
• W2138956466 creator A5040786852 @default.
• W2138956466 creator A5041647239 @default.
• W2138956466 creator A5044048476 @default.
• W2138956466 creator A5045889599 @default.
• W2138956466 creator A5048513986 @default.
• W2138956466 creator A5050337117 @default.
• W2138956466 creator A5053263882 @default.
• W2138956466 creator A5054842923 @default.
• W2138956466 creator A5057175194 @default.
• W2138956466 creator A5057201277 @default.
• W2138956466 creator A5059626751 @default.
• W2138956466 creator A5064407806 @default.
• W2138956466 creator A5064411138 @default.
• W2138956466 creator A5066413760 @default.
• W2138956466 creator A5071233417 @default.
• W2138956466 creator A5073444304 @default.
• W2138956466 creator A5074963804 @default.
• W2138956466 creator A5075022984 @default.
• W2138956466 creator A5077076177 @default.
• W2138956466 creator A5077749410 @default.
• W2138956466 date "2014-11-12" @default.
• W2138956466 modified "2023-10-17" @default.
• W2138956466 title "Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing" @default.
• W2138956466 cites W1771393170 @default.
• W2138956466 cites W1963821249 @default.
• W2138956466 cites W1982236424 @default.
• W2138956466 cites W1990182880 @default.
• W2138956466 cites W2003873813 @default.
• W2138956466 cites W2018380248 @default.
• W2138956466 cites W2032566422 @default.
• W2138956466 cites W2034293124 @default.
• W2138956466 cites W2034631326 @default.
• W2138956466 cites W2040963109 @default.
• W2138956466 cites W2051744393 @default.
• W2138956466 cites W2064050001 @default.
• W2138956466 cites W2068403109 @default.
• W2138956466 cites W2069663659 @default.
• W2138956466 cites W2072587374 @default.
• W2138956466 cites W2072931688 @default.
• W2138956466 cites W2074089003 @default.
• W2138956466 cites W2074393181 @default.
• W2138956466 cites W2114377387 @default.
• W2138956466 cites W2119818111 @default.
• W2138956466 cites W2131587128 @default.
• W2138956466 cites W2134063005 @default.
• W2138956466 cites W2134638008 @default.
• W2138956466 cites W2143602768 @default.
• W2138956466 cites W2144405756 @default.
• W2138956466 cites W2145922766 @default.
• W2138956466 cites W2147941657 @default.
• W2138956466 cites W2313827278 @default.
• W2138956466 cites W2314905147 @default.
• W2138956466 cites W2394626407 @default.
• W2138956466 cites W3125005447 @default.
• W2138956466 cites W3150370576 @default.
• W2138956466 doi "https://doi.org/10.1001/jama.2014.14601" @default.
• W2138956466 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4326249" @default.
• W2138956466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25326635" @default.
• W2138956466 hasPublicationYear "2014" @default.
• W2138956466 type Work @default.
• W2138956466 sameAs 2138956466 @default.
• W2138956466 citedByCount "1105" @default.
• W2138956466 countsByYear W21389564662014 @default.
• W2138956466 countsByYear W21389564662015 @default.
• W2138956466 countsByYear W21389564662016 @default.
• W2138956466 countsByYear W21389564662017 @default.
• W2138956466 countsByYear W21389564662018 @default.
• W2138956466 countsByYear W21389564662019 @default.
• W2138956466 countsByYear W21389564662020 @default.
• W2138956466 countsByYear W21389564662021 @default.
• W2138956466 countsByYear W21389564662022 @default.
• W2138956466 countsByYear W21389564662023 @default.
• W2138956466 crossrefType "journal-article" @default.
• W2138956466 hasAuthorship W2138956466A5000612576 @default.
• W2138956466 hasAuthorship W2138956466A5003762954 @default.
• W2138956466 hasAuthorship W2138956466A5005303346 @default.
• W2138956466 hasAuthorship W2138956466A5006247268 @default.
• W2138956466 hasAuthorship W2138956466A5006293085 @default.
• W2138956466 hasAuthorship W2138956466A5013612745 @default.

• next